`Horniak, David
`FW: Adapt Pharma v. Teva Pharms. | Document Production
`Tuesday, February 12, 2019 7:50:46 PM
`
`From:
`To:
`Subject:
`Date:
`
`HI David,
`
`Please see below which was served today.
`
`Thanks,
`Carol
`
`From: Consuelo.Durand <Consuelo.Durand@knobbe.com>
`Sent: Tuesday, February 12, 2019 3:39 PM
`To: mbruns@sternekessler.com
`Cc: Carol.Pitzel.Cruz <Carol.Pitzel.Cruz@knobbe.com>; 2cmp <2cmp@knobbe.com>
`Subject: Adapt Pharma v. Teva Pharms. | Document Production
`
`Dear Mr. Bruns:
`
`Please find below a link to documents produced by Indivior, Inc., bearing production numbers
`INDV000001-INDV000245. Please note the documents are designated Confidential – Outside
`Attorney’s Eyes Only, and should be treated as such in accordance with the protective order.
`
`https://knobbe.sharefile.com/d-s72129b148e24789b
`
`Sincerely,
`Consuelo
`
`Consuelo Durand
`Litigation Paralegal
`Consuelo.Durand@knobbe.com
`949-721-5386 Direct
`Knobbe Martens
`2040 Main St., 14th Fl.
`Irvine, CA 92614
`www.knobbe.com
`
`NOTICE: This email message is for the sole use of the intended recipient(s) and may contain confidential and
`privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not
`the intended recipient, please contact the sender by reply email and destroy all copies of the original
`message.
`
`Opiant Exhibit 2196
`Nalox-1 Pharmaceuticals, LLC v. Opiant Pharmaceuticals, Inc.
`IPR2019-00688
`Page 1
`
`